|
1
|
Colao A, Grasso LFS, Giustina A, Melmed S,
Chanson P, Pereira AM and Pivonello R: Acromegaly. Nat Rev Dis
Primers. 5(20)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Espinosa-de-los-Monteros AL, González B,
Vargas G, Sosa E and Mercado M: Clinical and biochemical
characteristics of acromegalic patients with different
abnormalities in glucose metabolism. Pituitary. 14:231–235.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
González B, Vargas G, de Los Monteros ALE,
Mendoza V and Mercado M: Persistence of diabetes and hypertension
after multimodal treatment of acromegaly. J Clin Endocrinol Metab.
103:2369–2375. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dal J, Feldt-Rasmussen U, Andersen M,
Kristensen LØ, Laurberg P, Pedersen L, Dekkers OM, Sørensen HT and
Jørgensen JO: Acromegaly incidence, prevalence, complications and
long-term prognosis: A nationwide cohort study. Eur J Endocrinol.
175:181–190. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Caron P, Brue T, Raverot G, Tabarin A,
Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F and
Chanson P: Signs and symptoms of acromegaly at diagnosis: The
physician's and the patient's perspectives in the ACRO-POLIS study.
Endocrine. 63:120–129. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Melmed S, Kleinberg D and Ho K: Pituitary
physiology and diagnostic evaluation. In: Williams Textbook of
Endocrinology. Melmed S (ed). Elsevier Saunders, Philadelphia, PA,
pp175-228, 2011.
|
|
7
|
Kalra J: Medical errors: An introduction
to concepts. Clin Biochem. 37:1043–1051. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Oyebode F: Clinical errors and medical
negligence. Med Princ Pract. 22:323–333. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kageyama K, Oki Y, Sakihara S, Nigawara T,
Terui K and Suda T: Evaluation of the diagnostic criteria for
Cushing's disease in Japan. Endocr J. 60:127–135. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Melmed S: Medical progress: Acromegaly. N
Engl J Med. 355:2558–2573. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kashou AH, Goyal A, Nguyen T and Chhabra
L: Atrioventricular Block. StatPearls, Treasure Island, FL,
2020.
|
|
12
|
Zemaitis MR, Boll JM and Dreyer MA:
Peripheral arterial disease. StatPearls, Treasure Island, FL,
2020.
|
|
13
|
Colao A, Auriemma RS, Galdiero M, Lombardi
G and Pivonello R: Effects of initial therapy for five years with
somatostatin analogs for acromegaly on growth hormone and
insulin-like growth factor-I levels, tumor shrinkage, and
cardiovascular disease: A prospective study. J Clin Endocrinol
Metab. 94:3746–3756. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Melmed S, Bronstein MD, Chanson P,
Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A,
Clemmons DR and Giustina A: A consensus statement on acromegaly
therapeutic outcomes. Nat Rev Endocrinol. 14:552–561.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zahr R and Fleseriu M: Updates in
diagnosis and treatment of acromegaly. Eur Endocrinol. 14:57–61.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ferrau F, Albani A, Ciresi A, Giordano C
and Cannavo S: Diabetes secondary to acromegaly: Physiopathology,
clinical features and effects of treatment. Front Endocrinol
(Lausanne). 9(358)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Haneda M, Noda M, Origasa H, Noto H, Yabe
D, Fujita Y, Goto A, Kondo T and Araki E: Japanese clinical
practice guideline for diabetes 2016. Diabetol Int. 9:1–45.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Oldfield EH, Jane JA Jr, Thorner MO,
Pledger CL, Sheehan JP and Vance ML: Correlation between GH and
IGF-1 during treatment for acromegaly. J Neurosurg. 126:1959–1966.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Matsubayashi K and Kawakami K: Prevalence,
incidence, comorbidities, and treatment patterns among Japanese
patients with acromegaly: A descriptive study using a nationwide
claims database. Endocr J: Jun 10, 2020 (Online ahead of
print).
|
|
20
|
Gadelha MR, Kasuki L, Lim DST and Fleseriu
M: Systemic complications of acromegaly and the impact of the
current treatment landscape: An update. Endocr Rev. 40:268–332.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kasuki L, Wildemberg LE and Gadelha MR:
MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the
treatment of acromegaly. Eur J Endocrinol. 178:R89–R100.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Graber ML: The incidence of diagnostic
error in medicine. BMJ Qual Saf. 22 (Suppl 2):ii21–ii27.
2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Katznelson L, Laws ER Jr, Melmed S,
Molitch ME, Murad MH, Utz A and Wass JA: Endocrine Society:
Acromegaly: An endocrine society clinical practice guideline. J
Clin Endocrinol Metab. 99:3933–3951. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Schöfl C, Franz H, Grussendorf M, Honegger
J, Jaursch-Hancke C, Mayr B and Schopohl J: participants of the
German Acromegaly Register: Long-term outcome in patients with
acromegaly: Analysis of 1344 patients from the German Acromegaly
Register. Eur J Endocrinol. 168:39–47. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mestron A, Webb SM, Astorga R, Benito P,
Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T,
Moreno B, et al: Epidemiology, clinical characteristics, outcome,
morbidity and mortality in acromegaly based on the Spanish
Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J
Endocrinol. 151:439–446. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fieffe S, Morange I, Petrossians P,
Chanson P, Rohmer V, Cortet C, Borson-Chazot F, Brue T and Delemer
B: French Acromegaly Registry: Diabetes in acromegaly, prevalence,
risk factors, and evolution: Data from the French Acromegaly
Registry. Eur J Endocrinol. 164:877–884. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bex M, Abs R, T'Sjoen G, Mockel J,
Velkeniers B, Muermans K and Maiter D: AcroBel-the Belgian registry
on acromegaly: A survey of the ‘real-life’ outcome in 418
acromegalic subjects. Eur J Endocrinol. 157:399–409.
2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Arosio M, Reimondo G, Malchiodi E,
Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S,
Losa M, Cannavò S, et al: Predictors of morbidity and mortality in
acromegaly: An Italian survey. Eur J Endocrinol. 167:189–198.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
American Diabetes Association: 4.
Comprehensive Medical Evaluation and Assessment of Comorbidities:
Standards of Medical Care in Diabetes-2019. Diabetes Care 42 (Suppl
1): S34-S45, 2019.
|
|
30
|
American Diabetes Association: 4.
Comprehensive Medical Evaluation and Assessment of Comorbidities:
Standards of Medical Care in Diabetes-2020. Diabetes Care 43 (Suppl
1): S37-S47, 2020.
|
|
31
|
Neale G, Hogan H and Sevdalis N:
Misdiagnosis: Analysis based on case record review with proposals
aimed to improve diagnostic processes. Clin Med (Lond). 11:317–321.
2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Singh H and Graber ML: Improving diagnosis
in health care-the next imperative for patient safety. N Engl J
Med. 373:2493–2495. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ball JR and Balogh E: Improving diagnosis
in health care: Highlights of a report from the National Academies
of Sciences, Engineering, and Medicine. Ann Intern Med. 164:59–61.
2016.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Committee on Diagnostic Error in Health
Care, Board on Health Care Services, Institute of Medicine, The
National Academies of Sciences, Engineering, and Medicine:
Improving diagnosis in health care. Balogh EP, Miller BT and Ball
JR (eds). National Academies Press (US), Washington, DC, 2015.
|
|
35
|
Mane KK, Rubenstein KB, Nassery N, Sharp
AL, Shamim EA, Sangha NS, Hassoon A, Fanai M, Wang Z and
Newman-Toker DE: Diagnostic performance dashboards: Tracking
diagnostic errors using big data. BMJ Qual Saf. 27:567–570.
2018.PubMed/NCBI View Article : Google Scholar
|
